CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept.

Stefania Masneri,Silvia Piantoni,Giorgio Galoppini,Francesca Regola,Cecilia Nalli,Chiara Bazzani,Franco Franceschini,Paolo Airò

Clinical and experimental rheumatology（2022）

引用 0|浏览5

暂无评分

摘要

CXCL-13 serum levels are raised in RA patients and decrease after therapy with ABA. We were not able to demonstrate that serum CXCL-13 levels predict the clinical response to ABA in RA patients.

查看译文

关键词

rheumatoid arthritis,serum

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要